Patent · US Active

Immunoenhancer-linked oligomeric HIV envelope peptides

US8936789B2 · kind B2 · utility

2Cited by

2References

15Claims

0Family size

Assignee

New York Blood Center, Inc. · US

Inventors

Shibo Jiang · Floral Park, US
Zhi Qi · Great Neck, US
Chungen Pan · Floral Park, US

Key dates

Filing date	Oct 16, 2009
Grant date	Jan 20, 2015
Priority date	—
Expiry date	Mar 22, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/16134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are immunogenic compositions comprising fusion proteins, the fusion proteins comprising lentivirus gp41 or a fragment thereof, a trimerization or oligomerization motif and an immunoenhancer that elicit potent and broad HIV neutralizing antibody responses in the immunized hosts. Also disclosed are methods of making and using the immunogenic compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.